Pressreleases

Gerresheimer Joins the Science Based Targets Initiative

Gerresheimer, innovative system and solution provider and global partner for the pharma and biotech industry, has joined the Science Based Targets initiative (SBTi). The organisation supports companies in using sound science to set and work toward targets for reducing greenhouse gas emissions. The SBTi will verify whether Gerresheimer’s own CO₂ reduction targets are in line with the Paris Agreement before transparently documenting the company’s progress on its platform.

Molnar at EUROANALYSIS 2023 Conference ‒ 27-31 August 2023 in Geneva, Switzerland

Molnár-Institute, a German company specialising in high-performance liquid chromatography (HPLC) solutions, will be attending the EUROANALYSIS 2023 trade fair taking place in Geneva, Switzerland, from 27 to 31 August.

RWS Rated Best Translation Agency for 2023 by Business2Community

Global language translation company RWS has been ranked as the #1 translation agency by market consultant Business2Community. This is the second consecutive year RWS has topped the Business2Community translation agency list.

Continuing the Success Story

Gerresheimer, an innovative system and solution provider and global partner for the pharma and biotech industry, is dedicating even more space to small-batch production. It has expanded the capacity of its small-batch production (SBP) area in Wackersdorf by removing a section of the high-bay warehouse and converting it into a manufacturing space. The new Small Batch Production Sampling Area Wackersdorf measures 700m² and will be used to manufacture pre-series parts for assembly systems. The expansion is a further display of Gerresheimer’s far-reaching industrialisation expertise in the manufacture of containment solutions, drug delivery systems and medical devices.

Gerresheimer Launches Open Innovation Programme for the Development of Home Therapy Solutions

As an innovative system and solution provider, Gerresheimer is the global partner for the pharma and biotech industry. In collaboration with ekipa, a leading incubator for open innovation, Gerresheimer is calling on startups, companies, students, researchers and young professionals to enable or improve patient care at home with (digital) services and solutions. The best solution will be awarded €4,000 in prize money and the winner can work together with Gerresheimer on further development. The call for entries starts now and ends on 27 August 2023.

Gerresheimer Continues Dynamic Growth in First Half of 2023

- Organic revenue growth of 16.6% in first half of 2023
- Adjusted EBITDA up 23.0% organically
- Production capacities expanded in Europe, the United States, and Mexico
- Guidance for full year 2023 confirmed

Gerresheimer: Annual General Meeting Backs Growth Course

– Dividend of €1.25 per share after strong financial year 2022
– High approval rates for all agenda items
– Forecast reaffirmed: double-digit growth in revenues and earnings

LTS Expands Into Large Molecule Drug Delivery with the Acquisition of the Sorrel Wearable Injection Device Business

LTS LOHMANN Therapie-Systeme (LTS), a leading pharmaceutical technology company that develops and manufactures innovative drug delivery systems such as Transdermal Patches (TTS), Oral Thin Films (OTF) and Micro Array Patches (MAP), announces the signing of the acquisition of the Sorrel wearable injection device business (Sorrel), a part of Eitan Medical.

Rethinking Pharmaceutical Glass Standards: The Need for Dedicated Testing Strategies

The US Pharmacopeia (USP) has proposed a revision to General Chapter <660> Container—Glass, which provides specifications for glass containers used in the pharmaceutical industry. These modifications aim to modernise tests and test methods alongside specifications within the chapter. The underlying goal is to create additional flexibility for packaging and storage requirements. However, many experts in the pharmaceutical industry believe that this is a short-sighted move.